Were you looking for information about Mycophenolate? Mycophenylate is a common misspelling of mycophenolate.
Anti-rejection medicines are given after transplant surgery to help prevent organ rejection. People who have received an organ transplant will usually need to take an anti-rejection medicine, such as mycophenolate (CellCept®, Myfortic®), for the rest of their lives. By decreasing the activity of the immune system, this drug helps prevent the body from perceiving a newly transplanted kidney, liver, or heart as a threat. This makes it less likely for the new organ to be rejected by the body.
(To read the full eMedTV article on this immunosuppressant, click Mycophenolate. You can also click any of the links in the box to the right for specific information.)